Bayview Legacy LLC sells 70K Arteris shares

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., reported an open-market sale of 70,000 shares of common stock on May 8, 2026 at a weighted average price of $31.1998 per share.

Rhea-AI Filing Summary

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., reported an open-market sale of 70,000 shares of common stock on May 8, 2026 at a weighted average price of $31.1998 per share. The trades occurred at prices ranging from $29.19 to $32.07 per share.

After this transaction, Bayview Legacy, LLC held 9,049,071 shares of Arteris common stock indirectly. The sale was executed under a Rule 10b5-1 trading plan adopted by K. Charles Janac, who manages Bayview Legacy, LLC and is deemed to have voting and dispositive power over these shares.

Insider Trade Summary 10b5-1

Net Seller: 70,000 shares

Net Sell 1 txn

Insider Bayview Legacy, LLC

Role 10% Owner

Sold 70,000 shs ($2.18M)

Type	Security	Shares	Price	Value
Sale	Common Stock	70,000	$31.1998	$2.18M

Holdings After Transaction: Common Stock — 9,049,071 shares (Indirect, See Footnote)

Footnotes (4)

1. F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on March 5, 2025.
2. F2. K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.
3. F3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.19 to $32.07 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. F4. K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.

Key Figures

Shares sold: 70,000 shares Weighted average sale price: $31.1998 per share Sale price range: $29.19–$32.07 per share +2 more

5 metrics

Shares sold 70,000 shares Open-market sale on May 8, 2026

Weighted average sale price $31.1998 per share Common stock sale on May 8, 2026

Sale price range $29.19–$32.07 per share Range of prices for multiple transactions

Shares held after transaction 9,049,071 shares Indirect holdings by Bayview Legacy, LLC after sale

10b5-1 plan adoption date March 5, 2025 Date plan adopted by K. Charles Janac

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, beneficial ownership, voting and dispositive power, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan that was adopted..."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"The price reported in Column 4 is a weighted average sale price."

beneficial ownership financial

"given his beneficial ownership of the reported security through Bayview Legacy, LLC..."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

voting and dispositive power regulatory

"is deemed to have voting and dispositive power over the shares..."

ten percent owner regulatory

"is_ten_percent_owner": 1"

FAQ

What insider transaction did Bayview Legacy, LLC report for Arteris (AIP)?

Bayview Legacy, LLC reported selling 70,000 shares of Arteris common stock. The open-market sale occurred on May 8, 2026 at a weighted average price of $31.1998 per share, within an intraday range of $29.19 to $32.07.

How many Arteris (AIP) shares does Bayview Legacy, LLC hold after the sale?

After the reported sale, Bayview Legacy, LLC holds 9,049,071 shares of Arteris common stock indirectly. This post-transaction figure shows that the LLC continues to own a large position despite the 70,000-share open-market disposition.

Was the Arteris (AIP) insider sale under a Rule 10b5-1 trading plan?

Yes. The filing states the sale was made pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2025. Such pre-arranged plans automate trading, indicating the timing of this 70,000-share sale was scheduled in advance.

What price range did Bayview Legacy, LLC receive for the Arteris (AIP) shares sold?

The weighted average sale price was $31.1998 per share, but individual trades ranged from $29.19 to $32.07. The filer notes they can provide detailed share counts at each specific price level upon request to interested parties.

Who controls Bayview Legacy, LLC’s Arteris (AIP) holdings according to the Form 4?

The filing explains that K. Charles Janac is the manager of Bayview Legacy, LLC and is deemed to have voting and dispositive power over its Arteris shares, giving him beneficial ownership through the LLC structure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/12/2026 - 05:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bayview Legacy, LLC

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CALIFORNIA 95008

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/08/2026		S(1)(2)		70,000	D	$31.1998(3)	9,049,071	I	See Footnote(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on March 5, 2025.

2. K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.

3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.19 to $32.07 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.

Remarks:

	/s/ K. Charles Janac	05/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)